|Relationship between 8-hydroxydeoxyguanosine levels in placental/umbilical cord blood and maternal/neonatal obstetric factors.|
|Jump to Full Text|
|PMID: 23181104 Owner: NLM Status: Publisher|
|Oxidative stress is associated with the development of various diseases including cancer, arteriosclerosis, diabetes mellitus, hypertension and metabolic syndrome. However, little is known about the involvement of 8-hydroxydeoxyguanosine (8-OHdG) during the perinatal period. At present, few studies have investigated the precise correlations between 8-OHdG levels in cord blood (CB) and the physical conditions of the mother and neonate. To clarify the involvement of 8-OHdG during the perinatal period, the relationships between CB 8-OHdG levels and maternal/neonatal characteristics in vaginal deliveries were determined. The 8-OHdG levels of CB units collected from singleton gestation vaginal deliveries were analyzed. The relationships between 8-OHdG levels and perinatal characteristics were analyzed. The 8-OHdG levels in CB ranged from 0.1 to 1.39 ng/ml (median, 0.37 ng/ml). The relationships between 8-OHdG levels and the perinatal data were analyzed. The 8-OHdG levels detected in the non-smoking group were significantly lower compared to those in the smoking group. However, no significant correlation was observed between 8-OHdG levels and other maternal/ neonatal factors, including umbilical artery acid/base and gas values. Maternal smoking increases the level of the oxidative DNA damage biomarker 8-OHdG in CB. Since oxidative stress may influence the long-term health outcomes of infants after birth, understanding maternal and fetus/neonate stress conditions at delivery may help improve the health of fetuses and infants.|
|Satoko Ebina; Takako Chiba; Takashi Ozaki; Ikuo Kashiwakura|
Related Documents :
|7304144 - Prognostic value of human placental lactogen (hpl) in an unselected obstetrical populat...
10879804 - Protein carbonyls and lipid peroxidation products as oxidation markers in preterm infan...
9779344 - Role of corticosteroids in neonatal blood pressure homeostasis.
19533504 - Neonatal pleural empyema in an extremely low birth weight infant.
24884424 - Domino: donor milk for improved neurodevelopmental outcomes.
21893934 - Stable precursor fragments of vasoactive peptides in umbilical cord blood of term and p...
|Type: JOURNAL ARTICLE Date: 2012-6-20|
|Title: Experimental and therapeutic medicine Volume: 4 ISSN: 1792-1015 ISO Abbreviation: Exp Ther Med Publication Date: 2012 Sep|
|Created Date: 2012-11-27 Completed Date: - Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 101531947 Medline TA: Exp Ther Med Country: -|
|Languages: ENG Pagination: 387-390 Citation Subset: -|
|Departments of Disability and Health and.|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): Exp Ther Med
Journal ID (iso-abbrev): Exp Ther Med
Journal ID (publisher-id): ETM
Publisher: D.A. Spandidos
Copyright © 2012, Spandidos Publications
Received Day: 15 Month: 5 Year: 2012
Accepted Day: 15 Month: 6 Year: 2012
Print publication date: Month: 9 Year: 2012
Electronic publication date: Day: 20 Month: 6 Year: 2012
Volume: 4 Issue: 3
First Page: 387 Last Page: 390
PubMed Id: 23181104
Publisher Id: etm-04-03-0387
|Relationship between 8-hydroxydeoxyguanosine levels in placental/umbilical cord blood and maternal/neonatal obstetric factors|
1Departments of Disability and Health and
2Radiological Life Sciences, Hirosaki University Graduate School of Health Sciences, Hirosaki 036-8564;
3Department of Obstetrics and Gynecology, Hirosaki National Hospital, Hirosaki 036-8545,
|Correspondence: Correspondence to: Professor Ikuo Kashiwakura, Department of Radiological Life Sciences, Hirosaki University Graduate School of Health Sciences, 66-1 Hon-cho, Hirosaki 036-8564, Japan, E-mail: firstname.lastname@example.org
Oxidative stress is defined as an imbalance in the pro-oxidant-antioxidant equilibrium in favor of pro-oxidants (1). It is known that there are relationships between oxidative stress and the development of various diseases such as cancer, arteriosclerosis, diabetes mellitus, hypertension and metabolic syndrome (1–6). The concentration of lipid peroxidation in peripheral blood is generally higher in pregnant women than in non-pregnant women because the rapidly growing fetoplacental unit in utero requires a large amount of oxygen (7–9). In addition, pregnancy-induced hypertension is associated with maternal oxidative stress (7,10–12).
Previous studies suggest that an oxidative DNA damage biomarker, 8-hydroxydeoxyguanosine (8-OHdG), is elevated in bladder carcinoma, prostate cancer (13), childhood cancers (14,15), diabetes mellitus (16,17), coronary heart disease (18) and myoma uteri (19), as well as in smokers (20–22). Moreover, the levels of 8-OHdG are higher in males than females (23,24). Maternal mental and physical stress during pregnancy increases not only pregnancy complications, such as miscarriage, premature birth and low birth weight, but also the risk of diseases in later life as well as hematopoietic dysfunction in the fetus/neonate (25,26). Furthermore, physiologically, pregnancy leads to an increase in free radicals due to the high energy demands of maternal physical functions and this causes maternal oxidization damage.
The placental/umbilical cord blood (CB) is the peripheral blood of the fetus; in addition, various hormones and molecules of oxidative stress derived from the maternal body are generally transported into the CB (27). Dziaman et al (28) reported that the levels of 8-OHdG in the urine of newborn children are ∼2.5 times higher than those of adult subjects, indicating that 8-OHdG may be a good marker of oxidative stress in newborns. However, little is known about the involvement of 8-OHdG during the perinatal period, and there have been few studies investigating the precise correlations between the levels of 8-OHdG in CB and the physical conditions of the mother and neonate. Knowing the level of 8-OHdG in CB may facilitate long-term health strategies after birth. In the present study, to clarify the involvement of 8-OHdG during the perinatal period, the relationships between the levels of CB 8-OHdG and maternal/neonatal characteristics in vaginal deliveries were determined.
Between November 2010 and April 2011, CB units were collected at a single Hospital (Hirosaki National Hospital, Hirosaki, Japan) after obtaining informed consent from all mothers and approval from the Committee of Medical Ethics of Hirosaki National Hospital (Hirosaki, Japan) and the Committee of Medical Ethics of Hirosaki University Graduate School of Medicine (Hirosaki, Japan). The inclusion criteria were singleton gestation vaginal deliveries and birth without resuscitation or immediate rescue procedures. A segment of the umbilical cord was double clamped immediately after neonatal delivery, and the blood was obtained from the umbilical vein before placental delivery (i.e., in utero collection). The CB was collected into a sterile collection bag containing 28 ml citrate phosphate dextrose anticoagulant (CBC-20; Nipro, Co., Osaka, Japan) until the flow ceased. A total of 28 CB units were collected and serum was separated within 24 h of CB collection. Eppendorf test tubes filled with separated serum were stored at −80°C until analysis for biochemical parameters. Relevant perinatal data (i.e., maternal age, smoking status, gestational age, duration of labor, birth weight, Apgar score, and umbilical artery acid/base status and gas values) were obtained from hospital records.
The concentration of 8-OHdG in CB was analyzed using highly sensitive 8-OHdG ELISA monitoring kits (Jaica, Fukuroi, Japan). Each assay was performed immediately after thawing of the serum sample. To remove high-molecular-weight proteins, which interfered with the analysis, each CB serum sample was filtered through an ultrafiltration membrane (molecular weight cut-off, 10,000; Amicon). The obtained filtrate was concentrated by a SpeedVac® centrifugal evaporator (Thermo Scientific Savant SPD1010; Thermo Fisher Scientific, Suwanee, GA, USA).
Statistical analysis was performed using SPSS software version 16.0 (SPSS Japan, Inc., Tokyo, Japan) and Origin (OriginLab, Northampton, MA, USA) for Windows. Descriptive statistics are presented as arithmetic median (range). Data were also analyzed by univariate analysis using the Mann-Whitney U test, Kruskal-Wallis test, and Spearman’s rank correlation coefficient depending on the distribution pattern of the data. The level of significance was set at P<0.05.
The perinatal data of the study population are summarized in Table I. The median maternal age was 30 years; 57.1% of the mothers were non-smokers and 42.9% were smokers. The median gestational duration was 38.5 weeks; 53.6% of the newborn infants were males and 46.4% were females. The median birth weight was 3047 g. The median Apgar scores at 1 and 5 min were both 9. The median umbilical arterial pH was 7.33, and base excess was −2.0 mM/l. The 8-OHdG levels in CB ranged from 0.1 to 1.39 ng/ml (median, 0.37 ng/ml).
The relationships between 8-OHdG levels and perinatal characteristics were analyzed. The 8-OHdG level detected in the non-smoking group was significantly lower than that in the smoking group (0.33 vs. 0.42 ng/ml, P<0.05) (Fig. 1). However, no significant correlation was observed between 8-OHdG levels and other maternal/neonatal factors, including umbilical artery acid/base and gas values. Four cases received oxygen during labor; the 8-OHdG levels in CB ranged from 0.13 to 0.41 ng/ ml. Both above-mentioned groups were further classified as primipara or multipara and male or female. No significant differences were observed between any subgroups (Fig. 2).
The relationships between CB 8-OHdG levels and biochemical markers and blood cells detected in the pre-delivery maternal peripheral blood were also analyzed. A significant positive correlation was found between 8-OHdG level and maternal white blood cells (data not shown). However, no significant correlation was observed between 8-OHdG level and maternal C-reactive protein (CRP), which is an inflammatory marker.
In the present study, the relationships between CB 8-OHdG levels and perinatal maternal/neonatal characteristics were determined. 8-OHdG is formed when DNA is oxidatively modified by reactive oxygen species (ROS). Thus, 8-OHdG is one of the most sensitive biomarkers of oxidative stress and is, therefore, widely used as a biomarker of oxidative DNA damage (29). Forlenza and Miller (30) report that serum 8-OHdG levels are much lower than urine 8-OHdG levels; serum 8-OHdG levels are ∼0.20 to 1.26 ng/ml in healthy adults. In addition, Schulpis et al (31) compared the 8-OHdG levels in CB between vaginal and Cesarean section deliveries; the mean 8-OHdG level was 0.25–0.27 ng/ml, indicating that there was no significant difference between delivery modes. In the present study, the 8-OHdG levels in CB obtained from singleton gestation vaginal deliveries ranged from 0.10 to 1.39 ng/ml (Table I), which is the same as that detected in healthy adult serum. In addition, the 8-OHdG levels in smokers were higher than those in non-smokers (Fig. 1). Tobacco causes the creation of ROS, which lead to DNA damage; this subsequently elevates 8-OHdG levels in urine and serum (20–22). Previous studies demonstrate that maternal smoking increases the risk of childhood disorders including preterm delivery (32), intrauterine growth retardation (IUGR), low birth weight (32,33), cleft lip/cleft palate (34), congenital heart disease (35) and attention-deficit hyperactivity disorder (36). Furthermore, some studies report that 8-OHdG levels are elevated in childhood cancer (14), diabetes mellitus (16,17) and coronary heart disease (18). The results of the present study do not indicate any relationships between 8-OHdG levels and various indicators of fetal developmental outcomes. However, additional approaches regarding the characteristics of oxidative stress during the perinatal period are required to improve the health and developmental outcomes of fetuses and infants.
Maternal leukocyte count is well known to increase during pregnancy. Although the mechanism underlying the increase in leukocytes is unclear, it is reported that the count is affected by cortisol, which increases during pregnancy and as a result of various placenta-derived cytokines (37). In the present study, a significant positive correlation was observed between CB 8-OHdG level and pre-delivery maternal white blood cell count (data not shown); meanwhile, CB 8-OHdG level was not related to CRP, an inflammatory response marker (data not shown). Because maternal leukocyte count was measured at different times depending on individuals, its precise changes were unclear. However, there may be a relationship between the number of leukocytes and 8-OHdG level as a result of maternal oxidative stress.
In conclusion, the results of the present study indicate that CB 8-OHdG levels in smokers are significantly higher than those in non-smokers. However, no relationship was found between 8-OHdG level and quantity or duration of smoking. Oxidative stress possibly influences the long-term health outcomes of infants. Although 8-OHdG is a relatively stable chemical substance, it can lead to G→T mutations during DNA replication if generated near chromosomal DNA, increasing the risk of cancer (2). Future investigations focusing on leukocytes, 8-OHdG level, and CB inflammatory cytokine levels are required. Healthcare personnel involved in perinatal medicine should try to reduce oxidative stress during pregnancy to improve the health of the fetus after birth.
This study was supported by a grant from Hirosaki University Institutional Research (2011). The study was performed by the research group of Ikuo Kashiwakura, who designed the study, performed a series of pilot experiments and had overall responsibility. The authors thank Ayako Tarakida who assisted with the collection of the CB units from normal vaginal deliveries at the Obstetrics and Gynecology Department of Hirosaki National Hospital (Hirosaki, Japan) and recorded all perinatal data of the study population. All authors contributed equally to the preparation of the manuscript.
|1..||Sies H. Oxidative stress: from basic research to clinical applicationAm J Med91S31S38Year: 1991|
|2..||Shibutani S,Takeshita M,Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodGNature349431434Year: 19911992344|
|3..||Ceriello A,Bortolotti N,Motz E,et al. Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemiaMetabolism4815031508Year: 199910599980|
|4..||Wu LL,Chiou CC,Chang PY,Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabeticsClin Chim Acta33919Year: 200414687888|
|5..||Olinski R,Siomek A,Rozalski R,et al. Oxidative damage to DNA and antioxidant status in aging and age-related diseasesActa Biochim Pol541126Year: 200717220955|
|6..||Cangemi R,Angelico F,Loffredo L,et al. Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: Effect of ascorbic acidFree Radic Biol Med43853859Year: 200717664149|
|7..||Little RE,Gladen BC. Levels of lipid peroxides in uncomplicated pregnancy: a review of the literatureReprod Toxicoll13347352Year: 199910560582|
|8..||Argüelles S,Machado MJ,Ayala A,Machado A,Hervias B. Correlation between circulating biomarkers of oxidative stress of maternal and umbilical cord blood at birthFree Radic Res40565570Year: 200616753833|
|9..||Burton GJ,Jauniaux E. Oxidative stressBest Pract Res Clin Obstet Gynaecol25287299Year: 201121130690|
|10..||Wang Y,Walsh SW. Placental mitochondria as a source of oxidative stress in pre-eclampsiaPlacenta19581586Year: 19989859861|
|11..||Morris JM,Gopaul NK,Endresen MJ,et al. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsiaBr J Obstet Gynaecol10511951199Year: 19989853769|
|12..||Ishihara O,Hayashi M,Osawa H,et al. Isoprostanes, prostaglandins and tocopherols in pre-eclampsia, normal pregnancy and non-pregnancyFree Radic Res38913918Year: 200415621708|
|13..||Chiou CC,Chang PY,Chan EC,Wu TL,Tsao KC,Wu JT. Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancersClin Chim Acta3348794Year: 200312867278|
|14..||Matsubasa T,Uchino T,Karashima S,et al. Oxidative stress in very low birth weight infants as measured by urinary 8-OHdGFree Radic Res36189193Year: 200211999387|
|15..||Yang Y,Tian Y,Yan C,Jin X,Tang J,Shen X. Determinants of urinary 8-hydroxy-2′-deoxyguanosine in Chinese children with acute leukemiaEnviron Toxicol24446452Year: 200918979530|
|16..||Hinokio Y,Suzuki S,Hirai M,Suzuki C,Suzuki M,Toyota T. Urinary excretion of 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathyDiabetologia45877882Year: 200212107732|
|17..||Nishikawa T,Sasahara T,Kiritoshi S,et al. Evaluation of urinary 8-hydroxydeoxyguanosine as a novel biomarker of macrovascular complications in type 2 diabetesDiabetes Care2615071512Year: 200312716813|
|18..||Collins AR,Gedik CM,Olmedilla B,Southon S,Bellizzi M. Oxidative DNA damage measured in human lymphocytes: large differences between sexes and between countries, and correlations with heart disease mortality ratesFASEB J1213971400Year: 19989761783|
|19..||Foksinski M,Kotzbach R,Szymanski W,Olinski R. The level of typical biomarker of oxidative stress 8-hydroxy-2′-deoxyguanosine is higher in uterine myomas than control tissues and correlates with the size of the tumorFree Rad Biol Med29597601Year: 200011033411|
|20..||Kasai H,Iwamoto-Tanaka N,Miyamoto T,et al. Life style and urinary 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage: effects of exercise, working conditions, meat intake, body mass index, and smokingJpn J Cancer Res92915Year: 200111173538|
|21..||Loft S,Svoboda P,Kasai H,et al. Prospective study of 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion and the risk of lung cancerCarcinogenesis2712451250Year: 200616364924|
|22..||Yano T,Shoji F,Baba H,Koga T,Shiraishi T,Orita H. Significance of the urinary 8-OHdG level as an oxidative stress marker in lung cancer patientsLung Cancer63111114Year: 200918676055|
|23..||Loft S,Vistisen K,Ewertz M,Tjønneland A,Overvad K,Poulsen HE. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass indexCarcinogenesis1322412247Year: 19921473230|
|24..||Suzuki K,Ito Y,Ochiai J,et al. The relationship between smoking habits and serum levels of 8-OHdG, oxidized LDL antibodies, Mn-SOD and carotenoids in rural Japanese residentsJ Epidemiol132937Year: 200312587611|
|25..||Lim FT,van Winsen L,Willemze R,Kanhai HH,Falkenburg JH. Influence of delivery on numbers of leukocytes, leukocyte subpopulations, and hematopoietic progenitor cells in human umbilical cord bloodBlood Cells20547558Year: 19947749120|
|26..||De Jongh RF,Puylaert M,Bosmans E,Ombelet W,Maes M,Heylen R. The fetomaternal dependency of cord blood interleukin-6Am J Perinatol16121128Year: 199910438193|
|27..||Knackstedt MK,Hamelmann E,Arck PC. Mothers in stress: consequences for the offspringAm J Reprod Immunol546369Year: 200516105097|
|28..||Dziaman T,Gackowski D,Rozalski R,Siomek A,Szulczynski J,Zabielski R. Urinary excretion rates of 8-oxoGua and 8-oxodG and antioxidant vitamins level as a measure of oxidative status in healthy, full-term newbornsFree Radic Res419971004Year: 200717729117|
|29..||Aruoma OI,Halliwell B,Gajewski E,Dizdaroglu M. Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelatesJ Biol Chem2642050920512Year: 19892584227|
|30..||Forlenza MJ,Miller GE. Increased serum levels of 8-hydroxy-2′-deoxyguanosine in clinical depressionPsychosom Med6817Year: 200616449405|
|31..||Schulpis KH,Lazaropoulou C,Vlachos GD,et al. Maternal-neonatal 8-hydroxy-deoxyguanosine serum concentrations as an index of DNA oxidation in association with the mode of labour and deliveryActa Obstet Gynecol Scand86320326Year: 200717364307|
|32..||Rogers JM. Tobacco and pregnancyReprod Toxicoll28152160Year: 200919450949|
|33..||Ward C,Lewis S,Coleman T. Prevalence of maternal smoking and environmental tobacco smoke exposure during pregnancy and impact on birth weight: retrospective study using Millennium CohortBMC Public Health781Year: 200717506887|
|34..||Little J,Card A,Munger RG. Tobacco smoking and oral clefts: a meta-analysisBull World Health Organ82213218Year: 200415112010|
|35..||Shi M,Wehby GL,Murray JC. Review on genetic variants and maternal smoking in the etiology of oral clefts and other birth defectsBirth Defects Res C Embryo Today841629Year: 200818383123|
|36..||Milberger S,Biederman J,Faraone SV,Chen L,Jones J. Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children?Am J Psychiatry15311381142Year: 19968780415|
|37..||Cunningham FG,Leveno KJ,Bloom SL,Hauth JC,Rouse DJ,Spong GYMaternal and fetal anatomy and physiologyWilliams Obstetrics23rd editionMcGraw HillNew York, NY114116Year: 2010|
Keywords: placental/umbilical cord blood, oxidative stress, 8-OHdG, smoking, white blood cells.
Previous Document: Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced he...
Next Document: Association between body mass index and breast cancer intrinsic subtypes in Japanese women.